References
- Cell v.56 he leucine repeat motif in fos protein modiates complex formation with Jun/AP-1 and is required for Transformation Schuermann M.;Neuberg M.;Hunter J. B.;Jenuwein T.;Ryseck R. P.;Bravo R.;Muler R.
- Cell v.54 The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes Chiu R.;Boyle W. J.;Meek J.;Smeal T.;Hunter T.;Karin M.
- Oncogene v.7 Transformation by Jun: requirement for leucine zipper, basic region and transactivation domin and enhancement by Fos Morgan I. M.;Ransone, L. J.;Bos T. J.;Verma I. M.;Vogt P. K.
- Cell v.54 Requirement ofr fos gene expression in the transcription activation of collagenase by other oncogenes and pholbol esters Schonthal A.;Herrlich P.;Rahmsdorf H. J.;Ponta H.
- Proc. Natl. Acad. Sci. USA v.88 The nuclear protooncogenes c-jun and c-fos as regulators of DNA replication Murakami Y.;Satake M.;Yamaguchi-Iwai Y.;Sakai M.;Muramatsu M.;Ito Y.
- Mol. Cell. Biol. v.11 The Jun and Fos protein families are both required for cell cycle progression in fibroblast Kovary K.;Bravo R.
- Bioessays v.17 Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products Hagmeyer B. M.;Angel P.;van Dam H.
- Proc. Natl. Acad. Sci. USA v.89 Induction of c-jun protooncogene expression and transcription factor AP-1 activity by the polyoma virus middle-sized tumor antigen Schonthal A.;Srinivas S.;Eckhart W.
- Nature v.346 Negative regulation of human c-fos expression by the retinoblastoma gene product Robbins P. D.;Horowitz J. M.;Mulligan R. C.
- Cell v.82 c-for is required for malignant progression of skin tumors Saez, E.;Rutberg, S. E.;Mueller, E.;Oppenheim, H.;Smoluk, J.;Yuspa, S. H.;Spiegelman B. M.
- Cell v.62 Antitumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone Jonat, C.;Rahmsdorf, H.;park, K.-K.;Cato, A. B. C.'Gebel, S.;Ponta, H.;Herrlich, P.
- Mol. Cell. biol. v.13 Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro Kerppola T. K.;Luk, D.;Curran T.
- Oncogene v.12 Overex-pression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition Soprano D. R.;Chen L. X.;Wu, S.;donigan A. M.;Borghaei R. C.;Soprno K. J.
- Human & Exp. Toxic. v.14 no.2 The ying-yang of RAR and AP-1: cancer treatment without overt toxicity Allenby G.
- Anti-Cancer Drugs v.6 Inhibition of breast and ovarian carcinoma cell growth by 1, 25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone Saunders D. E.;Christensen C.;Wiliams, J. R.;Wappler N. L.;Lawrence W. D.;Malone J. M.;Malviya V. K.;Deppe G.
- Oncogene v.9 Retinoic acid suppresses polyoma virus transformation by inhibiting transcription of the c-fos proto-oncogene Talmage D. A.;Listerud M.
- Cancer Res. v.56 Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element Li, J. J.;Dong Z.;Dawson M. I.;Colburn N. H.
- 향약(생약)대사전 정보섭(외)
- unpublished results Park, K.-K
- Carcinogenesis v.16 Signal integration at the c-fos promoter Janknecht R.;Cahill M. A.;Nordheim A.
- Nature v.334 Induction of proto-oncogene Jun/AP-1 by serum and TPA Lamph W. W.;Wamsley P.;Sassone-Corse P.;Verma I. M.
- Mol. Cell. Biol. v.15 Doxorubicine-induced Id2A gene transcription is targeted at an activating transcription factor/cyclic AMP prsponse element motif through novel mechanism involving protein kinases distinct from protein kinase C and protein kinase A.